Introduction
The picornaviruses are a large family of viruses responsible for a number of clinically and economically important diseases. These include poliomyelitis, the common cold, hepatitis A and foot-and-mouth disease. They are among the smaller viruses, having an Mr of approximately 8.5 × 106 of which about 30~ is nucleic acid. The genome is positive-sense ssRNA which is encapsidated in an icosahedral protein shell made up of 60 copies of each of four proteins, VP1 to VP4. Virus proteins 1 to 3 are exposed on the surface of the particle whereas VP4 is internal and modified at its amino terminus by the addition of myristic acid (Chow et aL, 1987; Paul et al., 1987) . Myristic acid occupies a position in the core of mature poliovirus particles; it has been suggested that it may be important for particle integrity or in the localization of the capsid protein precursor on the hydrophobic membranes during virion assembly (Chow et al., 1987) .
To determine the function of the amino-terminal myristylation of VP4 in picornaviruses, and to establish whether competition for the acylation site is a possible approach to antiviral chemotherapy, we have been examining the effect of fatty acids on virus replication. Some fatty acids are able to enter picornavirus-infected cells and compete for the myristylation site on VP4 (J. F. E. Newman, unpublished observations). Unexpectedly, we have found that short chain fatty acids also inhibit an early event in the replication of bovine enterovirus (BEV) at concentrations which have no detectable effect on cellular macromolecular synthesis and cloning. Our findings indicate that fatty acids inhibit cell-mediated uncoating.
Methods
Viruses and cells. Poliovirus type 1 (NIV-DI49/86) and coxsackievirus B5 (ATCC VR-185) were cultivated in Vero cells; BEV (VG-5-27; McFerran, 1962) and encephalomyocarditis virus (EMCV) (ATCC VR-I29B) were cultivated in BHK-21 cells (except where indicated otherwise), and human rhinovirus type 1B (HRV-1 B) (obtained from Dr D. V. Sangar, Wellcome Biotechnology, Beckenham, U.K.) was cultivated in HeLa cells. All cells were grown as monolayers in 75 ml plastic flasks in Eagle's MEM (Gibco) containing 10% foetal calf serum. HRV-1B was grown at 33 °C whereas all other viruses were grown at 37 °C.
Radiolabelling of virus. Monolayers of BHK-21 cells were infected
with BEV at a multiplicity of approximately 100 p.f.u./cell at 37 °C. After a 1 h adsorption period the monolayers were washed three times with methionine-free medium (MFM) and then incubated in MFM containing [3~Slmethionine (Amersham) at 10 ~tCi/ml. After approximately 7 h, when the cells had become detached from the flask, the culture was transferred to -70 °C. After freezing and thawing twice the virus was purified using the method described by Brown & Cartwright (1963) .
Radiolabelling of virus-directed proteins. Monolayers of BHK-21,
HeLa and Vero cells were infected at multiplicities of 100 with appropriate viruses at 37 °C (33 °C for HRV-1B). The infecting virus was allowed to attach to the cells for 1 h after which the monolayers were washed twice with MFM. Cells infected with BEV, poliovirus, coxsackievirus and EMCV were incubated for a further 1 h then rewashed with MFM, Cells infected with HRV were incubated for 4 h before being washed again with MFM. Infected cells were then incubated with [35S]methionine at 51tCi/ml. After a further 1 h, infected monolayers were washed with phosphate-buffered saline at 4 °C, the radiolabelled proteins were recovered from cells with 2~ SDS and 2~ 2-mercaptoethanol and analysed on 10~ polyacrylamide gels (Laemmli, 1970) .
Fatty acid treatment of viruses. Fatty acids at 10 mM in ethanol were rapidly injected, at room temperature, into vigorously stirred aqueous virus samples in glass bottles to obtain a final concentration of 100 pM. The mixture was then used immediately to infect cells or held at room temperature for 1 h before infection. For extraction of the fatty acid a BEV/lauric acid mixture was added to an equal volume of chloroform and shaken for I min at room temperature. The mixture was then centrifuged at 1000 g for 5 rain and the radioactivity in each phase was determined, or the virus in the aqueous phase was used to infect BHK-21 cells.
Results

Effect of fatty acids on picornavirus-directed protein synthesis
As indicated, our original intention was to confine our attention to competing for the myristylation site on picornavirus protein VP4. H o w e v e r in experiments to determine the effect of fatty acid on infected cell m a c r o m o l e c u l a r synthesis, we observed that fatty acids present during infection had a m a r k e d effect on the production of BEV proteins. These experiments indicate that lauric acid, present at the time of infection with BEV, prevents both the virusinduced inhibition of cellular protein synthesis and the synthesis of virus-directed proteins. However, when the fatty acid was added to BEV-infected cells 5 min postinfection a typical virus-directed protein pattern was obtained (Fig. 2, lane 14) . These findings suggest that lauric acid directly inhibits an early event in virus replication. As found with other compounds which inhibit early events in picornavirus replication (McSharry et al., 1979) we have found that adding the fatty acid to the infecting virus for up to 1 h before infection produced a more clear-cut inhibition of virus protein synthesis. BEV treated with 100 ~tM-lauric acid and cultivated in Vero cells also showed a complete cutoff of virus protein synthesis, demonstrating that inhibition was not confined to one cell type (data not shown).
To establish whether other fatty acids and simple derivatives could inhibit BEV infection we mixed a number of compounds at 100 pM with virus for 1 h before infecting BHK-21 cells. We had determined previously, by microscopy and the synthesis of host cell proteins, that these compounds at 100 pou were not toxic for BHK-21 cells in culture. The polyacrylamide gel separation in Fig.  2 shows that capric acid (C10, lane 3) failed to inhibit virus protein synthesis but some host protein is visible. 
Attachment of virus to susceptible cells
To determine whether fatty acid inhibition of BEV replication was due to a failure of the virus to attach to cell receptors, purified [35S]methionine-labelled virus was added to BHK-21 cell monolayers in the presence and absence of 1001aM-lauric acid. Aliquots were removed from the infecting virus at intervals and the amount of unadsorbed virus was measured on a scintillation counter. Fig. 3 shows that there is a rapid association of radiolabelled BEV with the BHK-21 cells with approximately 4 0~ of the input being cellassociated within 4 min. The attachment kinetics for radiolabelled virus in the presence and absence of lauric acid were similar.
Binding of lauric acid to virus particles
Purified unlabelled BEV was mixed with 5~tCi
[3H]lauric acid and allowed to stand at 20 °C for 30 min. Virus-bound fatty acid was then assayed by centrifugation of the virus through a linear sucrose gradient. shows radioactive lauric acid at the same position as the virus on a gradient, suggesting that binding had occurred. When the peak fractions were pooled and extracted with chloroform the radioactive fatty acid was recovered in the organic phase (data not shown). The non-virucidal reversible binding of fatty acid was confirmed when it was found that chloroform extraction of lauric acid-treated BEV allowed virus replication to occur (Fig. 5, lane 4) . In a similar binding experiment radiolabelled lauric acid bound only poorly to poliovirus particles.
Stabilization of virus particles with lauric acid
To examine the effect of fatty acids on virus stability [3SS]methionine-labelled BEV was heated in the presence and absence of lauric acid. Thermal degradation was assayed by sucrose gradient centrifugation. Fig. 6 (b) shows that heating at 52 °C for 1 h caused the breakdown of BEV particles, with a radioactive peak sedimenting at about 80S compared with 160S for untreated virus (Fig.  6a ). In the presence of 100 ~tM-lauric acid, breakdown due to heating was significantly reduced (Fig. 6c) . Using 1 mM-lauric acid it was found later that complete protection from degradation at 52 °C could be achieved.
In similar experiments 1001~M-lauric acid failed to stabilize poliovirus 1 (data not shown).
Inhibition of cell-mediated uncoating
As lauric acid was found to bind to and stabilize BEV particles, while still allowing attachment to susceptible cells, we determined whether virus particles could undergo cell-mediated uncoating.
[3SS]methioninelabelled BEV was added to BHK-21 cell monolayers in the presence or absence of 1001xM-lauric acid. After incubation at 37 °C for 1 h the cells were washed with fresh medium and then lysed with a mixture of 0-5~ sodium deoxycholate and 1 ~o NP40. Radioactivity in the cell lysate was assayed by sucrose gradient centrifugation. Fig. 7(b) shows that after 1 h a significant proportion of the virus, added to cells in the absence of lauric acid, sedimented to about 80S compared with 160S for the control virus (Fig. 7a) . Most of the radioactive virus material extracted from cells infected with BEV in the presence of lauric acid sedimented to 160S (Fig. 7 c) .
Owing to the difficulty in making this type of experiment fully quantitative it is possible that the finding of only 160S particles in Fig. 7 (c) could be due to 80S particles being rendered unstable by the presence of lauric acid. However we believe that this is unlikely in view of our findings in other experiments where infected cells have been incubated for 4 h. In cells infected with virus alone there was an almost complete absence of 160S particles whereas in cells infected with virus, in the presence of lauric acid, 160S particles were readily detected. The block in the formation of eclipse products is similar to that described for poliovirus treated with Arildone (Everaert et al., 1989) and suggests that bound lauric acid prevents cell-mediated uncoating.
Discussion
We have shown that short chain fatty acids have a marked effect on the replication of BEV but this activity does not appear to extend to other picornaviruses or even other members of the enterovirus genus. The presence of lauric acid early in infection inhibits BEV-directed protein synthesis almost completely while having negligible effect on that of poliovirus type 1, coxsackievirus B5, EMCV and HRV-1B. Studies with BEV suggest that lauric acid binds to the virus particle and stabilizes its structure against heat degradation. Bound lauric acid has no effect on the ability of the virus to attach to susceptible cells but does appear to prevent cell-mediated uncoating. The binding site for fatty acids has not been determined; however the interaction between the virus particle and laurie acid is reversible with chloroform, suggesting that it is due to hydrophobic bonding and that it is not virucidal.
Our findings are similar to those described for a number of other compounds which are capable of inhibiting the uncoating of picornaviruses while not interfering with attachment and penetration of host cells (Lonberg-Holm & Noble-Harvey, 1973; Longberg-Holm et al., 1975; Ninomiya et al., 1984; Tisdale & Selway, 1984 , Otto et al., 1985 Smith et al., 1986; Kenny et al., 1988; Rossmann, 1989) . Detailed studies by Rossmann and his colleagues, using X-ray crystallography, have shown that the antiviral activity of a series of compounds synthesized by the Sterling Winthrop Institute (WIN compounds) is due to a strong hydrophobic bonding occurring in a small pocket found in the floor of the canyon which encircles each of the 12 vertices on HRV-14 particles. Following this finding it was proposed that viral uncoating is inhibited by the drug preventing the collapse of the hydrophobic pocket or by blocking the flow of ions to the interior of the virus particle (Smith et al., 1986) . The cross-resistance of HRV-IB to Arildone, SDS and dichloroflavan suggests that these compounds share common binding sites (Tisdale & Selway, 1984) and Rossmann (1989) has suggested that compounds that inhibit the uncoating of picornaviruses probably all bind at essentially the same hydrophobic site. The finding that fatty acids interact hydrophobically and require a carbon chain length length of 12 to 15 to inhibit the replication of BEV suggests that these molecules may also have to fit into a restricted hydrophobic domain. This possible restriction of size and hydrophobicity is similar to that found for some WIN compounds where aliphatic chains of 5 or 7, linking oxazoline-phenoxy groups and the isoxazole group, produce molecules that fit best into the hydrophobic pocket of HRV-14 (Smith et al., 1986) . Our finding that capric acid (C10) did not inhibit BEV may indicate that it is not sufficiently hydrophobic to have a high affinity for the hydrophobic domain in the virus particle. Previously it has been shown that increasing the hydrophobicity of some WIN compounds, by suitable additions to the phenyl group, increased their antiviral activity (Smith et al., 1986) . Similarly, removal of hydrophobic substituents from Arildone decreased antiviral activity (Diana et al., 1977) .
The observation that WIN compounds 51711 and 52084 inhibit rhino-and polioviruses but not mengo, foot-and-mouth disease (FMDV) and hepatitis A viruses is thought to reflect small differences in capsid structure (Smith et al., 1986) . Mengovirus, which is structurally similar to HRV-14, has a partially blocked hydrophobic pocket which may influence accessibility to WIN compounds. The specificity of compounds such as the chalcone Ro 09-0410, which inhibits rhinoviruses but is ineffective against coxsackie-, echo-, polio-and mengoviruses (Ishutsuka et al., 1982; Ninomiya et al., 1984) , the inhibition of HRV-2 but not HRV-14 by low concentrations ofSDS (Lonberg-Holm & Noble-Harvey, 1973 ) and the findings presented in this communication are less easy to explain and may argue against a common binding site. We cannot rule out the possibility that the poliovirus type 1 (a South African isolate made in 1986), HRV-1B and the coxsackievirus B5 used in this study (for which there are no structural data) may have inaccessible hydrophobic pockets. However this appears to be unlikely in the case of poliovirus, as recent experiments have shown that poliovirus type 1 (LSc) is also not inhibited by laurie acid (J. F. E. Newman, unpublished observations). It is also possible that fatty acids, even if they enter the canyon pockets of these viruses, are not retained there because of insufficient hydrophobic affinity. Smith et al. (1986) have presented comparative data showing differences in amino acids found in the hydrophobic pockets of poliovirus, HRV and FMDV which suggest that such variable size, shape and affinity is possible. If this model for the hydrophobic pocket is correct, our findings would suggest that fatty acids with chain lengths of 12 to 15 are of the correct size and shape to penetrate BEV particles and, because of a high affinity, become tightly bound. An alternative explana-tion might be that there are other sites on some picornaviruses that interact with hydrophobic fatty acids in such a way that uncoating is inhibited. It has been proposed for the anti viral chalcone Ro 09-0410 that some rhinoviruses have specific binding sites on their capsids not found on other picornaviruses (Ninomiya et al., 1984) . Competition studies with WIN compounds and RNA sequence analysis of escape mutants should go some way to answering this question.
